Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Monreal

Showing results (321-330 of 451) with videos related to

Pageof 46
Sort By:
International Journal of Cardiology|January 20, 2020
Inferior vena cava agenesis in patients with lower limb deep vein thrombosis in the RIETE registry. When and why to suspectAntonella Tufano, Luciano López-Jiménez, Behnood Bikdeli, et al.
Journal of Thrombosis and Thrombolysis|February 1, 2018
Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolismAmir Kuperman, Raquel López-Reyes, Lopez-Saez Juan Bosco, et al.
Thrombosis Research|October 17, 2020
Corrigendum to "Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism" [Thromb. Res. 193 (2020) 160-165]Javier Trujillo-Santos, Patricia Beroiz, Farès Moustafa, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|June 9, 2026
Distinct Predictors of Post-thrombotic Symptoms, Signs, and Ulcers after a First Episode Deep Vein Thrombosis: A RIETE Registry StudyPedro Parra-Caballero, Jean-Philippe Galanaud, Paolo Prandoni, et al.
The American Journal of Medicine|December 24, 2017
Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous ThromboembolismChatree Chai-Adisaksopha, Alfonso Iorio, Mark A Crowther, et al.
Vascular Medicine (London, England)|September 30, 2022
Clinical characteristics and outcomes in patients with retinal vein occlusionMiguel Martín Romero, Vladimir Salazar Rosa, Pablo Demelo Rodríguez, et al.
European Journal of Internal Medicine|March 26, 2016
Analysis of environmental risk factors for pulmonary embolism: A case-crossover study (2001-2013)Javier de Miguel-Díez, Rodrigo Jiménez-García, Ana López de Andrés, et al.
Thrombosis Research|August 14, 2020
Evaluation of the SAMe-TT2R2 score to predict the quality of anticoagulation control in patients with venous thromboembolism treated with vitamin K antagonists: Findings from the RIETE registryJorge Del-Toro-Cervera, Pablo Demelo-Rodriguez, Francisco Galeano-Valle, et al.
Thrombosis Research|July 6, 2020
Rivaroxaban or apixaban in fragile patients with acute venous thromboembolismJavier Trujillo-Santos, Patricia Beroiz, Farès Moustafa, et al.
Thrombosis Research|March 18, 2020
Thirty-day outcomes in patients with proximal deep vein thrombosis who discontinued anticoagulant therapy prematurelyJosé A Nieto, Damian Mora, Behnood Bikdeli, et al.
Pageof 46

Showing results (321-330 of 451) with videos related to

Sort By:
Pageof 46
International Journal of Cardiology|January 20, 2020
Inferior vena cava agenesis in patients with lower limb deep vein thrombosis in the RIETE registry. When and why to suspectAntonella Tufano, Luciano López-Jiménez, Behnood Bikdeli, et al.
Journal of Thrombosis and Thrombolysis|February 1, 2018
Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolismAmir Kuperman, Raquel López-Reyes, Lopez-Saez Juan Bosco, et al.
Thrombosis Research|October 17, 2020
Corrigendum to "Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism" [Thromb. Res. 193 (2020) 160-165]Javier Trujillo-Santos, Patricia Beroiz, Farès Moustafa, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|June 9, 2026
Distinct Predictors of Post-thrombotic Symptoms, Signs, and Ulcers after a First Episode Deep Vein Thrombosis: A RIETE Registry StudyPedro Parra-Caballero, Jean-Philippe Galanaud, Paolo Prandoni, et al.
The American Journal of Medicine|December 24, 2017
Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous ThromboembolismChatree Chai-Adisaksopha, Alfonso Iorio, Mark A Crowther, et al.
Vascular Medicine (London, England)|September 30, 2022
Clinical characteristics and outcomes in patients with retinal vein occlusionMiguel Martín Romero, Vladimir Salazar Rosa, Pablo Demelo Rodríguez, et al.
European Journal of Internal Medicine|March 26, 2016
Analysis of environmental risk factors for pulmonary embolism: A case-crossover study (2001-2013)Javier de Miguel-Díez, Rodrigo Jiménez-García, Ana López de Andrés, et al.
Thrombosis Research|August 14, 2020
Evaluation of the SAMe-TT2R2 score to predict the quality of anticoagulation control in patients with venous thromboembolism treated with vitamin K antagonists: Findings from the RIETE registryJorge Del-Toro-Cervera, Pablo Demelo-Rodriguez, Francisco Galeano-Valle, et al.
Thrombosis Research|July 6, 2020
Rivaroxaban or apixaban in fragile patients with acute venous thromboembolismJavier Trujillo-Santos, Patricia Beroiz, Farès Moustafa, et al.
Thrombosis Research|March 18, 2020
Thirty-day outcomes in patients with proximal deep vein thrombosis who discontinued anticoagulant therapy prematurelyJosé A Nieto, Damian Mora, Behnood Bikdeli, et al.
Pageof 46